Clinical Trial Update: Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of NFL-101 for nicotine dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• NFL-101

Snippet

Sponsor: NFL Biosciences SAS | Conditions: Smoking Cessation, Nicotine Dependence | Phase 2 | Status: COMPLETED